Hydrogen sulfide, a toxic gas, at low concentrations is also a biological mediator in animals. In the colon, hydrogen sulfide is produced by intestinal tissues and gut sulfur bacteria. Gutderived molecules undergo liver metabolism. Portal hypertension is one of the most common complications contributing to the high mortality in liver cirrhosis. We hypothesized that the colon-derived hydrogen sulfide may affect portal blood pressure. Sprague-Dawley rats were maintained either on tap water (controls) or on water solution of thioacetamide to produce liver cirrhosis (CRH-R). Hemodynamics were measured after administration of either saline or Na 2 S, a hydrogen sulfide donor, into (1) the colon, (2) the portal vein, or (3) the femoral vein. Expression of enzymes involved in hydrogen sulfide metabolism was measured by RT-PCR. CRH-R showed a significantly higher portal blood pressure but a lower arterial blood pressure than controls. Saline did not affect hemodynamic parameters. In controls, intracolonic hydrogen sulfide decreased arterial blood pressure and portal blood flow but increased portal blood pressure. Similarly, hydrogen sulfide administered into the portal vein decreased arterial blood pressure but increased portal blood pressure. In contrast, hydrogen sulfide administered into the systemic vein decreased both arterial and portal blood pressures. CRH-R showed significantly greater responses to hydrogen sulfide than controls. CRH-R had a significantly higher liver concentration of hydrogen sulfide but lower expression of rhodanese, an enzyme converting hydrogen sulfide to sulfate. In conclusion, colon-administered hydrogen sulfide increases portal blood pressure while decreasing the systemic arterial blood pressure. The response to hydrogen sulfide is more pronounced in cirrhotic rats which show reduced hydrogen sulfide liver metabolism. Therefore, colon-derived hydrogen sulfide may be involved in the regulation of portal blood pressure, and may contribute to portal hypertension.
Introduction
Hydrogen sulfide (H 2 S) has been known as a toxic gas in medical literature for three centuries. Namely, in 1713, in his book entitled De Morbis Articum Diatriba, Bernardino Ramazzini described the toxic effects of the gas in victims of the occupational exposure. 1 However, accumulating evidence suggests that H 2 S is also an important biological mediator in the circulatory system. 2, 3 Thus far, the research has been focused mainly on the cardiovascular effects of H 2 S produced enzymatically by vasculature, the kidneys, and the heart. Interestingly, recent evidence indicates that the circulatory system may also be influenced by
Impact statement
Accumulating evidence suggests that gutderived molecules affect the control of the circulatory system. Mechanisms controlling liver circulation have been profoundly studied; however, the effects of gut bacteria-derived molecules on portal blood pressure have not been established. In the colon, hydrogen sulfide is produced by intestinal tissues and gut sulfur bacteria. We found that colon-administered hydrogen sulfide increases portal blood pressure while decreasing the systemic arterial blood pressure. The hemodynamic response to hydrogen sulfide was more pronounced in cirrhotic rats which showed reduced hydrogen sulfide liver metabolism, i.e. lower expression of rhodanese, an enzyme converting hydrogen sulfide to sulfate. We propose that colon-derived hydrogen sulfide may affect the regulation of portal and arterial blood pressures and may be involved in portal hypertension.
colon-derived H 2 S. 4, 5 In fact, colon may be the largest pool of H 2 S in mammals. This is because H 2 S and its derivatives are produced by both intestinal tissue and gut sulfur bacteria. 6, 7 Blood collected from intestines transports numerous nutrients and gut bacteria products via the portal vein to the liver. Although the mechanisms controlling liver circulation have been profoundly studied, the effects of gut bacteria-derived molecules on portal blood pressure have not been established. We hypothesized that the colonderived H 2 S may affect arterial blood pressure (ABP) and portal blood pressure. Since portal hypertension is one of the most common complications contributing to the high mortality rate in liver cirrhotic patients, we investigated the effects of the colon-derived H 2 S in healthy and in cirrhotic animals.
Materials and methods

Ethical approval, animals, and model of liver cirrhosis
The experiments were performed according to Directive 2010/63 EU on the protection of animals used for scientific purposes and approved by the I Local Bioethical Committee in Warsaw (permission: 103/2016). Rats were housed in groups (3-4 animals) in polypropylene cages with environmental enrichment, 12-h light/12-h dark cycle, temperature [22] [23] C, humidity 45-55%, food and water ad libitum.
Measurements were performed on 28-week-old, male, Sprague Dawley rats (n ¼ 69, healthy rats) and Sprague Dawley rats with liver cirrhosis (n ¼ 54, cirrhotic rats) fed a standard laboratory diet ad libitum. Liver cirrhosis was induced by administering thioacetamide in a drinking water 0.3 g/L for 18 weeks, as previously described. 8, 9 Cirrhosis was confirmed by histopathological examination with hematoxylin and eosin staining, using a standard light microscope Olympus BX41 and CellSens software (Olympus Corporation, Tokyo, Japan).
Surgical preparation
Rats were anaesthetized with urethane 1.5 g/kg of bw i.p. First, an arterial catheter was implanted into the aorta via the femoral artery for ABP measurements (all the experimental series). Next, a venous catheter was implanted into the femoral vein for peripheral infusions (series evaluating hemodynamic effects of H 2 S administration into peripheral vein). Next, the portal vein was catheterized for portal blood pressure (PBP) measurements (all the experimental series). Specifically, skin and muscles were cut from the xiphoid to the navel. The portal vein and the superior mesenteric vein were dissected from adjacent tissue and stabilized with ligatures. A polyurethane T-shape catheter (ID 0.6 mm, OD 1 mm) with the tip made of a 27 G, 0.5 cm long, blunt needle was inserted into the portal vein via the superior mesenteric vein. The extravascular part of the catheter was secured to the mesentery with a single surgical knot and an adhesive glue. Subsequently, the abdominal cavity was closed. The hemodynamic measurements were performed with the Biopac MP 150 recording system (Biopac Systems, Goleta, USA).
Hemodynamic measurements
The measurements started 60 min after the induction of anesthesia.
Hemodynamic effects of H 2 S administration into the colon. Intracolonic infusions were performed by means of a flexible catheter inserted into the colon, 8 cm from the anus.
A pilot dose-response study. In healthy rats, ABP and PBP were recorded for 15 min at baseline and 20 min after intracolonic infusions of Na 2 S at the following doses: 0.08 mmol Na 2 S/kg/b.w. (n ¼ 7), 0.8 mmol Na 2 S/kg/b.w. (n ¼ 7), 2.4 mmol Na 2 S/kg/b.w. (n ¼ 7).
The effect of intracolonic infusions on portal blood flow and ABP. The experiments were performed in healthy rats (n ¼ 7). Measurements of portal vein blood flow (PBF) were conducted using the transit time ultrasound set-up (T106, Transonic System Inc., Ithaca, NY, USA). PBF and ABP were measured at baseline, for 30 min after intracolonic administration of 0.5 mL of saline, and 30 min after intracolonic administration of Na 2 S at a dose of 2.4 mmol/kg/b.w.
Hemodynamic effects of H 2 S administration into the colon in healthy and cirrhotic rats. 
Determination of the H 2 S level in liver homogenates
The frozen liver samples were homogenized at a ratio of 1/10 with ice-cold 50 mM phosphate buffer pH 8.0 for 1 min at 8000-9500 r/min using a blender homogenizer. H 2 S level was determined in homogenates after 1 h of incubation with L-cysteine, using the method described in Kartha et al. 10 with modifications described by Bronowicka-Adamska et al. 11 Methylene blue was spectrophotometrically detected at 670 nm. The standard curve was linear at the concentration range of 0-250 mM with a correlation coefficient of 0.994.
RT-PCR
Isolation of total RNA. Total RNA was extracted from the liver using TRIzol reagent (Invitrogen, CA, USA) following the manufacturer's instructions. RNA concentration was estimated by measuring the absorbance at 260 nm. Isolated RNA was characterized for quantity and integrity and was stored at À80 C for RT-PCR analysis.
Reverse transcription of RNA. Reaction volume was 20 mL and components were used including 3 mg of total RNA, Oligo d(T) primer 0.5 mg/ml (1ml; Thermo Scientific), GoScript TM 5Â Reaction buffer (4 ml, Promega Corporation), MgCl 2 (3 ml), GoScript TM Reverse Transcriptase 160 U/ml (1ml, Promega Corporation), RNase Inhibitor 20 U/ml (1ml, Thermo Scientific) and dNTP mix 10 mM (1 mL, Thermo Scientific). RNA was mixed with Oligo d(T) primer and was heated for 5 min at 70 C. Then, samples were incubated in the reaction mixture for 5 min at 25 C, 60 min at 42 C, and 15 min at 70 C.
Polymerase chain reaction. PCR was performed using 2 ml of cDNA, 0.2 mM of each primer, 0.04 U/ml of DNA polymerase (Thermo Scientific) in 10 mM buffer Tris-HCl pH 8.8 (supplemented with 1.5 mM MgCl 2 , 50 mM KCl, 0.1% Triton X-100), 0. 0 GTGAAACAAGCTAGGT GGGC3 0 (antisense) for MPST, 339bp; 5 0 ACCCGCGAGT ACAACCTTCTT3 0 (sense) and 5 0 GCCGTGTTCAATGG GGTACT3 0 (antisense) for b-actin, 285bp. PCR products were analyzed by electrophoresis on 2.0% agarose gel stained with ethidium bromide, visualized under ultraviolet light, and analyzed by densitometric analysis using the system of documentation and computer analysis UVI-KS 4000i/ImagePC (Syngen Biotech).
Compounds
Urethane, Na 2 S, L-cysteine, pyridoxal phosphate (PLP), sodium dihydrogen phosphate dihydrate pure, sodium sulfite, agarose, and N,N-dimethyl-p-phenylenediamine sulfate salt were obtained from Sigma-Aldrich (St. Louis, MO, USA). Ferric chloride, zinc acetate dehydrate pure, trichloroacetic acid (TCA), and sodium hydroxide were from Polskie Odczynniki Chemiczne S.A. (Gliwice, Poland).
Statistics
Mean ABP and PBP were calculated on the blood pressure tracing by AcqKnowledge 4.3.1 (Biopac Systems, Goleta, USA). For the evaluation of ABP, PBP, and PBF response to the treatment, the average over 1 min baseline was compared with the averages over 1 min after the treatment by means of one-way analysis of variance (ANOVA) for repeated measures. Differences between the groups were evaluated by multivariate ANOVA, followed by Tukey's post hoc test or t-test, when appropriate. The Kolmogorov-Smirnov test was used to test normality of the distribution. A value of two-sided P < 0.05 was considered significant. Means AE SE are presented. Analyses were conducted using STATISTICA 12.0 (Stat Soft, Krakow, Poland).
Results
Hemodynamic and histological characterization of healthy and cirrhotic rats
At baseline, PBP was significantly higher in cirrhotic rats (11.1 AE 0.2, n ¼ 30) than in healthy rats (6.0 AE 0.3, n ¼ 30), P < 0.05. In contrast, mean ABP was significantly lower in cirrhotic rats (84.9 AE 1.9, n ¼ 30) than in healthy rats (101.3 AE 2.0, n ¼ 30), P < 0.05.
Histopathological examination showed no pathological changes in livers of rats that drank tap water (healthy rats). In rats treated with thioacetamide the following pathological findings were present: large hepatic nodules separated by bands of connective tissue, hyperplasia of connective tissue (around portal fields and on the periphery of nodules), and extension of central veins and portal venules. In the parenchyma, hepatocytes with degenerative changes dominated. The changes can be classified as an incomplete septal cirrhosis or early cirrhosis, with the features of macronodular cirrhosis (Figure 1 ).
There was no significant difference between healthy and cirrhotic rats in liver test, underlining the chronic cirrhotic process without decompensated liver failure. Healthy rats (n ¼ 12): AST(U/L) 97.5 AE 11.3, ALT(U/L) 60.7 AE 3.6, total protein (g/dL) 5.27 AE 0.07, albumins (g/dL) 3.65 AE 0.04; and Cirrhotic rats (n ¼ 12): AST(U/L) 110.8 AE 12.7, ALT (U/L) 64.8 AE 3.4, total protein (g/dL) 5.31AE 0.08, albumins (g/dL) 3.76 AE 0.07.
Hemodynamic effects of H 2 S administration into the colon
A pilot dose-response study. In healthy rats, intracolonic administration of Na 2 S produced a significant increase in PBP in all the series, i.e. 0.08 mmol/kg/b.w. (F 2,12 ¼ 18.84, P < 0.05), 0.8 mmol/kg/b.w. (F 2,12 ¼ 4.69, P < 0.05), and 2.4 mmol/kg/b.w. (F 2,12 ¼ 6.61, P < 0.05), which was followed by a decrease in PBP (Figure 2(a) ). The changes in PBP were In healthy rats, Na 2 S at a dose of 0.8 mmol/kg/b.w. (F 3,15 ¼ 10.37, P < 0.05) and 2.4 mmol/kg/b.w. (F 3,18 ¼ 3.91, P < 0.05) produced a significant increase in PBP (Figure 4  (a) ). There were significant differences between the vehicle and 0.8 mmol/kg/b.w. and 2.4 mmol/kg/b.w. series (F 2,16 ¼ 11.43, P < 0.05).
Cirrhotic rats showed a significant increase in PBP after administration of Na 2 S at a dose of 0. (Figure 4(b) ). In the latter series, all rats died due to significant hypotension. There were significant differences between the vehicle and 0.8 mmol/kg/b. w. and 2.4 mmol/kg/b.w. series (F 2,15 ¼ 6.61, P < 0.05). Cirrhotic group treated with Na 2 S at a dose of 2.4 mmol/ kg/b.w. showed a significantly higher increase in PBP than the healthy group treated with Na 2 S at the same dose (F 1,11 = 7.27, P < 0.05) (Figure 4(a) and (b) ).
Changes in ABP. Administration of the vehicle did not affect ABP.
In healthy rats, Na 2 S at a dose of 0.8 mmol/kg/b.w. (F 9,45 ¼ 10.48, P < 0.05) and 2.4 mmol/kg/b.w. (F 9,54 ¼ 24.90, P < 0.05) produced a significant decrease in ABP (Figure 4(c) ). There were significant differences between the vehicle and 0.8 mmol/kg/b.w. and 2.4 mmol/kg/b.w. series (F 2,16 =15.68, P < 0.05).
Cirrhotic rats exhibited a significant decrease in ABP after administration of Na 2 S at a dose of 0.8 mmol/kg/b. w. (F 9,45 ¼ 10.48, P < 0.05) and 2.4 mmol/kg/b.w. (F 9,45 ¼ 27.51, P < 0.05) (Figure 4(d) ). In the latter series, all rats died due to significant hypotension. There were significant differences between the vehicle and 0. ........................................................................................................................................................ 
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Cirrhotic rats treated with Na 2 S at a dose of 2.4 mmol/ kg/b.w. showed a significantly greater decrease in ABP than healthy rats (F 1,11 ¼ 6.87, P < 0.05) (Figure 4 (c) and (d)).
Hemodynamic effects of H 2 S administration into the portal vein
Changes in PBP. Administration of the vehicle did not produce a significant change in PBP.
In healthy rats, Na 2 S at a dose of 0.04 mmol/kg/b.w. produced a not significant increase in PBP, whereas Na 2 S at a dose of 0.4 mmol/kg/b.w. produced a significant increase in PBP (F 7,35 ¼ 29.99, P < 0.05) ( Figure 5(a) ). There were significant differences between the vehicle and 0.4 mmol/kg/b.w. series (F 1,10 =16.77, P < 0.05).
In cirrhotic rats, Na 2 S at a dose of 0.04 mmol/kg/b.w. caused a significant increase in PBP (F 7,35 ¼ 13.27, P < 0.05). Administration of Na 2 S at a dose of 0.4 mmol/kg/b.w. resulted in a biphasic response, i.e. a transient decrease in PBP followed by a significant increase in PBP (F 7,35 ¼ 63.94, P < 0.05) ( Figure 5(b) ). There were significant differences between the vehicle and 0.4 mmol/kg/b.w. series (F 1,10 ¼ 59.70, P < 0.05).
Cirrhotic rats showed significantly greater increase in PBP than healthy rats after administration of Na 2 
Hemodynamic effects of H 2 S administration into the peripheral vein
Changes in PBP. Administration of the vehicle did not affect PBP.
In healthy rats, Na 2 S at a dose of 0.04 mmol/kg/b.w. (F 2,10 ¼ 3.83, P < 0.05) and 0.4 mmol/kg/b.w. (F 5,25 ¼ 27.73, P < 0.05) produced a significant decrease in PBP (Figure 6  (a) ). In the latter series, all rats died due to a significant hypotension after 15 min. There were significant differences between the vehicle and 0.4 mmol/kg/b.w. series (F 1,10 ¼ 38.65, P < 0.05).
In cirrhotic rats, there was a significant decrease in PBP after administration of Na 2 S at a dose of 0.04 mmol/kg/b. w. (F 2,10 ¼ 4.77, P < 0.05) and 0.4 mmol/kg/b.w. (F 5,25 ¼ 28.46, P < 0.05) and in the latter series all rats died due to a significant hypotension after 10 min (Figure 6(b) ). ........................................................................................................................................................ 
....
There were significant differences between the vehicle and 0.4 mmol/kg/b.w. series (F 1,10 ¼ 42.03, P < 0.05).
Namely, cirrhotic rats showed a significantly greater decrease in PBP than healthy rats (F 1,10 ¼ 7.18, P < 0.05) in 0.4 mmol/kg/b.w. series (Figure 6(a) and (b) ). ........................................................................................................................................................ .... (Figure 6(c) ). There were significant differences between the vehicle and 0.4 mmol/kg/b.w. series (F 1,10 ¼ 27.66, P < 0.05).
Changes in ABP.
Cirrhotic rats showed a significant decrease in ABP after administration of Na 2 S at a dose of 0.04 mmol/kg/b.w. The between-group analysis revealed a significant difference between healthy and cirrhotic groups after administration of Na 2 S at a dose of 0.4 mmol/kg/b.w. Namely, cirrhotic rats that received Na 2 S at a dose of 0.04 mmol/kg/ b.w. showed a significantly greater decrease in ABP than healthy rats (F 1,10 ¼ 5.19, P < 0.05) (Figure 6(c) and (d) ).
H 2 S generation
Livers of cirrhotic rats showed a significantly higher concentration of H 2 S after 1 h of incubation with L-cysteine (17.8 AE 1.6 nmol H 2 S/g of tissue, n ¼ 14) than livers of healthy rats (10.4 AE 0.9 nmol H 2 S/g of tissue, n ¼ 15).
Expression of sulfurtransferases
In cirrhotic rats, the expression of TST in liver was decreased twofold as compared to the healthy group. We did not observe any statistically significant differences in the expression of mRNA of CTH, CBS, and MPST genes between healthy and cirrhotic rats (Figure 7 ).
Discussion
A new finding of our study is that colon-administered H 2 S increases PBP while decreasing systemic ABP in rats. Furthermore, we found that cirrhotic rats show an augmented hemodynamic response to H 2 S, which is associated with a significantly lower expression of rhodanese, an enzyme converting H 2 S to sulfate. H 2 S has been found to play an important role in the control of ABP 12 ; however, the mechanisms are not clear. This is in part because H 2 S may exert its biological effects via its derivatives such as S-nitrosothiols, thiosulfates as well as interacting with nitric oxide and carbon monoxide. 13, 14 Interestingly, similarly to epinephrine, H 2 S may act as a vasoconstrictor or as a vasorelaxant, depending on a type of vascular bed and the dose. 15 In rodents, H 2 S donors have been found to produce a significant hypotensive effect, associated with peripheral vasodilatation. 12 Likewise, in the present study Na 2 S, the most commonly used H 2 S donor administered intravenously lowered ABP.
Hemodynamic studies on H 2 S have thus far focused on the effects of H 2 S produced enzymatically by blood vessels, the heart, kidneys, or the brain. However, recent studies suggest that the gut-derived H 2 S may also contribute to the regulation of systemic ABP. 5 As a matter of fact, large intestine may represent the largest pool of H 2 S in the body, since H 2 S is produced by both intestinal tissue and gut bacteria. 6, 7 Accordingly, the estimated concentration of H 2 S in the blood and other tissues has been reported to be within the micromolar 16 or nanomolar range, 17 in contrast to millimolar concentrations in the intestines. 18, 19 Previously, Ebrahimkhani et al., 20 hypothesized that H 2 S may be responsible for changes in the portal circulation. However, to the best of our knowledge, the effect of colon-derived H 2 S on PBP has not been studied.
Recently, we have found that colonic administration of H 2 S decreases systemic ABP, which is associated with an increased portal blood levels of thiosulfate and sulfane sulfur, products of H 2 S oxidation. 5 Before entering the systemic circulation, blood collected from the colon passes the liver. Therefore, in the present study, we evaluated if colon-derived H 2 S may affect the liver circulation. In particular, we assessed the effect of H 2 S on concomitant changes in PBP and systemic ABP, a major factor influencing PBP by changing intestinal blood flow.
Portal blood pressure depends on blood volume flowing from portal vein and hepatic artery, and on the resistance offered by the terminal portal venules, the sinusoids, and the roots of hepatic venules (liver resistance). The liver does not control PBF, which is simply the outflow from intestines, spleen, and pancreas. However, changes in PBF produce compensatory response from hepatic artery, a mechanism known as hepatic arterial buffer response. Interestingly, it has been suggested that this mechanism may also involve H 2 S signaling. 21 In the present study, we have found that intracolonic administration of H 2 S increases PBP, which is accompanied by a drop in systemic ABP. Furthermore, we have found that rats infused with H 2 S into the colon showed a similar pattern of hemodynamic response to rats infused with H 2 S directly into the portal vein. Besides, the intracolonic administration of H 2 S decreased PBF. These suggest that an increase in PBP after intracolonic administration of H 2 S was caused by an increase in the liver resistance. This concept may also be supported by studies by Norris and collaborators, who found the constriction of liver sinusoids after administration of H 2 S into the splenic vein. 22 Interestingly, in our study, the highest PBP was present in rats treated with smaller doses of H 2 S which produced a smaller systemic hypotension. Furthermore, PBP was increasing as systemic ABP was returning to baseline values after the H 2 S treatment. These data strongly suggest that the H 2 S-driven increase in PBP was reduced by the concomitant H 2 S-induced systemic hypotension (Figure 8) .
In contrast to rats infused with H 2 S into the colon or into the portal vein, rats infused with H 2 S into the femoral vein showed a significant decrease in both, ABP, and PBP. These findings show that the H 2 S-dependent increase in PBP requires a direct delivery of H 2 S from the colon. Otherwise, the systemic hypotension produced by H 2 S outweighs the pressor effect of H 2 S on portal circulation. This is likely due to the hypotension-driven decrease in the liver blood flow and/or too small amount of H 2 S reaching portal circulation after systemic administration of the H 2 S donor.
Interestingly, there are some studies suggesting that H 2 S may decrease PBP. Distrutti et al. 23 and Fiorucci et al.
24
found that NaHS, another fast-releasing H 2 S donor, reversed hepatic vasoconstriction induced by norepinephrine and homocysteine. However, those experiments were performed in a perfused liver model which may not fully reflect physiological conditions, and the effect of NaHS could depend on the increased concentration of noradrenaline and cysteine. Tan et al. 25 found that intraperitoneal treatment with NaHS, twice a day reduced portal pressure in CCL 4 -induced liver cirrhosis. However, the authors did not evaluate the effect of H 2 S on PBP in healthy animals, and did not record ABP. Therefore, a decrease in PBP could be secondary to systemic hypotension. Furthermore, it is of note, that although the authors used NaHS, a fast-releasing H 2 S donor, they observed long-term effects (days).
This may suggest that their findings were dependent on other than H 2 S-dependent effects. In this respect, NaHS similar to Na 2 S dissociates rapidly in plasma leading to instant formation of H 2 S and a short-lasting increase in plasma level of H 2 S and its derivatives. 26 This is reflected in short-term changes in hemodynamic parameters after a single parenteral administration of H 2 S donors. 27 Portal hypertension is a major complication of liver cirrhosis. Cirrhotic patients often present systemic hypotension caused by peripheral vasodilatation, which is mediated by nitric oxide and other vasorelaxant factors 28, 29 ; however, the mechanisms have not been fully elucidated. Interestingly, in our study, the intracolonic treatment of healthy animals with H 2 S produced similar hemodynamic characteristics, i.e. an increased PBP and a decreased systemic ABP. Moreover, the hemodynamic response to H 2 S was greater in cirrhotic than in healthy rats.
The greater hemodynamic response to H 2 S in cirrhotic rats seems to be caused by a reduced metabolism of H 2 S in cirrhotic livers. H 2 S is synthetized in the liver by 3-mercapropyruvate sulfurtransferase (MPST), cystathionine b-synthase (CBS), and gamma-cystathionase (CTH). 30 Here, we found that cirrhotic livers showed higher concentration of H 2 S after liver homogenate incubation with L-cysteine, a substrate for H 2 S synthesis. However, there are no significant difference between healthy and cirrhotic rats in the liver expression of MPST, CBS, and CTH. These data, together with Km values for the enzymes, which were substantially above intracellular cysteine concentrations, 31 suggest that the higher concentration of H 2 S in cirrhotic livers was due to the smaller rate of H 2 S degradation rather than the higher enzymatic production of H 2 S. In this respect, in our study, cirrhotic livers showed downregulated expression of rhodanese which converts H 2 S into sulfate, thereby diminishing H 2 S level. 32 Rhodanese is an enzyme located in the mitochondria 33 and is susceptible to oxidative stress 34 which accompanies liver injury. 35 The importance of the liver, and likely rhodanese, in detoxifying or buffering the amount of the gut-derived H 2 S entering the systemic circulation was notably evident in rats treated with higher doses of H 2 S. Namely, cirrhotic rats developed a significant systemic hypotension leading to death, whereas healthy rats showed only a transient hypotension.
Taking together, our findings imply that the gut-derived H 2 S contributes to the regulation of PBP and ABP. Moreover, it may produce harmful hemodynamic effects in liver cirrhosis by augmenting portal hypertension and systemic hypotension.
A limitation of our study is that thioacetamide-induced liver cirrhosis may not reflect the whole spectrum of liver Figure 8 . A proposed interplay between the effects of H 2 S on systemic arterial blood pressure (arterial pressure) and portal blood pressure (portal pressure). On the one hand, H 2 S increases portal pressure increasing liver resistance. On the other hand, H 2 S decreases portal blood pressure indirectly, by lowering systemic arterial pressure and intestinal blood flow.
cirrhosis caused by numerous factors, such viral infections that may differently affect biochemical activity of the liver. 36 However, in our study, histological and hemodynamic characteristics of cirrhotic rats were like those found in liver cirrhosis of various origin in humans.
In conclusion, colon-administered H 2 S increases PBP while decreasing systemic ABP in rats. Importantly, the hemodynamic effects are more pronounced in cirrhotic animals which exhibit decreased expression of rhodanese, an enzyme transforming H 2 S to other sulfur compound. Therefore, the gut-derived H 2 S may contribute to the control of portal and ABPs, and may be involved in the etiology of portal hypertension and systemic hypotension in liver cirrhosis. Further studies on hemodynamic effects of gutderived molecules, such as H 2 S, are needed.
